Course Description

Your NIH submission did not go as planned. Now what? In this course, I will help you understand when you should consider a resubmission or not, and why. We walk through the decision-making involved: A1 or A0? Same NOFO, study section, IC, agency? When should you resubmit, and how will it affect ESI status? After heavy emphasis on planning and strategizing, we discuss effective strategies for writing the resubmission, particularly the all-important Introduction.

Updated: August 20, 2024

Preview an Excerpt of this Course

Course Details

Who:  Designed for those considering an NIH resubmission for an upcoming grant deadline and the people who advise them.

When:  Available on demand

Cost:  $499

Learning Objectives

At the end of this 1 hour and 40 minutes session, participants will be able to:

  1. Utilize your Summary Statement to help you plan and strategize for the A1
  2. Identify key decision-making points during the planning process and apply the tips imparted in this course to make those decisions
  3. Develop grantwriting skills to write a responsive, strong, persuasive NIH A1

Content Disclaimer

Course content updated August 20, 2024. Content of this course was updated and re-recorded on this date. The content was accurate at that time. We recommend that you search for changes that may have occurred to the content since the recording date. Note that the course title may have been modified slightly since the recording. 

I wanted to express how beneficial the Master Resubmissions virtual course was for me. The insights and guidance provided significantly helped me prepare my R21 resubmission, especially in crafting the Introduction page.

In my initial A0 grant submission to the NCI, I received a 13th percentile score. After applying what I learned from your course, my A1 resubmission improved to a 5th percentile score and was funded.

Thank you for providing such a valuable resource. It has made a meaningful impact on my grant-writing journey.

Giovanni Nigita, PhD, Department of Cancer Biology and Genetics, Top 5 Largest Cancer Hospital